NO20071321L - Anti-inflammatoriske midler - Google Patents

Anti-inflammatoriske midler

Info

Publication number
NO20071321L
NO20071321L NO20071321A NO20071321A NO20071321L NO 20071321 L NO20071321 L NO 20071321L NO 20071321 A NO20071321 A NO 20071321A NO 20071321 A NO20071321 A NO 20071321A NO 20071321 L NO20071321 L NO 20071321L
Authority
NO
Norway
Prior art keywords
group
inflammatory drugs
compounds
adamantanmethyl
bicyclooctyl
Prior art date
Application number
NO20071321A
Other languages
English (en)
Norwegian (no)
Inventor
David John Grainger
David John Fox
Original Assignee
Cambridge Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33017302&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20071321(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cambridge Entpr Ltd filed Critical Cambridge Entpr Ltd
Publication of NO20071321L publication Critical patent/NO20071321L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
NO20071321A 2004-08-11 2007-03-12 Anti-inflammatoriske midler NO20071321L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0417863A GB2418425B (en) 2004-08-11 2004-08-11 Anti-inflammatory agents
PCT/GB2005/003133 WO2006016152A1 (en) 2004-08-11 2005-08-10 Anti-inflammatory agents

Publications (1)

Publication Number Publication Date
NO20071321L true NO20071321L (no) 2007-05-11

Family

ID=33017302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071321A NO20071321L (no) 2004-08-11 2007-03-12 Anti-inflammatoriske midler

Country Status (21)

Country Link
US (2) US7691845B2 (cg-RX-API-DMAC7.html)
EP (1) EP1781299B1 (cg-RX-API-DMAC7.html)
JP (2) JP4991540B2 (cg-RX-API-DMAC7.html)
KR (1) KR101341965B1 (cg-RX-API-DMAC7.html)
CN (1) CN101014347B (cg-RX-API-DMAC7.html)
AT (1) ATE492280T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005271062B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514250A (cg-RX-API-DMAC7.html)
CA (1) CA2576257C (cg-RX-API-DMAC7.html)
DE (1) DE602005025493D1 (cg-RX-API-DMAC7.html)
DK (1) DK1781299T3 (cg-RX-API-DMAC7.html)
ES (1) ES2357588T3 (cg-RX-API-DMAC7.html)
GB (1) GB2418425B (cg-RX-API-DMAC7.html)
IL (1) IL181055A (cg-RX-API-DMAC7.html)
MX (1) MX2007001626A (cg-RX-API-DMAC7.html)
NO (1) NO20071321L (cg-RX-API-DMAC7.html)
NZ (1) NZ553718A (cg-RX-API-DMAC7.html)
PL (1) PL1781299T3 (cg-RX-API-DMAC7.html)
RU (2) RU2410376C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006016152A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700827B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2418425B (en) 2004-08-11 2008-09-03 Univ Cambridge Tech Anti-inflammatory agents
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
GB2430674B (en) * 2005-08-10 2010-11-17 Univ Cambridge Tech Anti-inflammatory agents
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
US7803794B2 (en) 2005-06-15 2010-09-28 Cambridge Enterprise Limited Anti-inflammatory agents
GB2451451A (en) * 2007-07-30 2009-02-04 Inion Ltd Osteogenic compounds
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
GB2455539B (en) * 2007-12-12 2012-01-18 Cambridge Entpr Ltd Anti-inflammatory compositions and combinations
GB201009603D0 (en) * 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent
CN105367495B (zh) * 2014-08-29 2019-07-23 中国人民解放军第二军医大学 含有七元内酰胺环的荜拔酰胺类似物及其制备与应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7216662A (cg-RX-API-DMAC7.html) * 1972-12-08 1974-06-11
DE2758822C2 (de) * 1977-12-30 1987-01-15 Diehl GmbH & Co, 8500 Nürnberg Verfahren zur Herstellung eines Kupfer-Zink-Werkstoffes
DE3217373A1 (de) * 1982-05-08 1983-11-10 Bayer Ag, 5090 Leverkusen Sulfinyl- und sulfonyl-azacycloheptan-2-one, verfahren zu ihrer herstellung sowie ihre verwendung als futterzusatzstoffe
US4908445A (en) * 1989-01-09 1990-03-13 Harbor Branch Oceanographic Institution, Inc. Sesquiterpene compounds and pharmaceutical compositions containing same, from pachastrella sponges
IT1247698B (it) * 1990-06-21 1994-12-30 Sigma Tau Ind Farmaceuti 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
GB9026256D0 (en) * 1990-12-03 1991-01-16 Fujisawa Pharmaceutical Co Hexahydroazepine derivatives
US5854234A (en) * 1993-10-21 1998-12-29 G. D. Searle & Co. Amidino dervatives useful as nitric oxide synthase inhibitors
JP3633060B2 (ja) 1995-09-22 2005-03-30 Ｊｓｒ株式会社 低結晶性エチレン系ランダム共重合体およびその組成物
JP4125790B2 (ja) * 1996-12-20 2008-07-30 アストラゼネカ・アクチエボラーグ トリアゾロ［４，５−ｄ］ピリミジニル誘導体および医薬としてのその使用
JP3690052B2 (ja) * 1997-03-24 2005-08-31 Ｊｓｒ株式会社 オイルゲル化剤
JP2003146972A (ja) * 2001-11-14 2003-05-21 Teikoku Hormone Mfg Co Ltd カルボスチリル誘導体
KR100606102B1 (ko) * 2002-08-03 2006-07-28 삼성전자주식회사 방송/통신 통합형 수동 광네트웍 시스템
WO2004022536A1 (en) * 2002-09-04 2004-03-18 Glenmark Pharmaceuticals Limited New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
US7326677B2 (en) 2003-07-11 2008-02-05 The Procter & Gamble Company Liquid laundry detergent compositions comprising a silicone blend of non-functionalized and amino-functionalized silicone polymers
AU2005212073B2 (en) 2004-02-18 2010-07-08 Kyorin Pharmaceutical Co., Ltd. Bicyclic amide derivatives
GB2418425B (en) * 2004-08-11 2008-09-03 Univ Cambridge Tech Anti-inflammatory agents
US20120015196A1 (en) * 2007-01-29 2012-01-19 Guardian Industries Corp. Method of making heat treated coated article using diamond-like carbon (dlc) coating and protective film on acid-etched surface
US20120015195A1 (en) * 2007-01-29 2012-01-19 Guardian Industries Corp. and C.R.V.C. Method of making heat treated and ion-beam etched/milled coated article using diamond-like carbon (dlc) coating and protective film
US20120040160A1 (en) * 2007-01-29 2012-02-16 Guardian Industries Corp. Method of making heat treated and ion-beam etched/milled coated article using diamond-like carbon (dlc) protective film

Also Published As

Publication number Publication date
EP1781299A1 (en) 2007-05-09
CA2576257C (en) 2013-02-12
ATE492280T1 (de) 2011-01-15
ZA200700827B (en) 2008-09-25
AU2005271062A1 (en) 2006-02-16
GB2418425B (en) 2008-09-03
RU2007104519A (ru) 2008-09-20
KR20070060081A (ko) 2007-06-12
HK1099200A1 (en) 2007-08-10
NZ553718A (en) 2010-02-26
RU2410376C2 (ru) 2011-01-27
PL1781299T3 (pl) 2011-05-31
EP1781299B1 (en) 2010-12-22
JP2012140444A (ja) 2012-07-26
US8497261B2 (en) 2013-07-30
GB0417863D0 (en) 2004-09-15
AU2005271062B2 (en) 2011-04-14
MX2007001626A (es) 2007-06-25
KR101341965B1 (ko) 2013-12-17
RU2010142847A (ru) 2012-04-20
US7691845B2 (en) 2010-04-06
US20100292213A1 (en) 2010-11-18
DE602005025493D1 (de) 2011-02-03
JP2008509210A (ja) 2008-03-27
CN101014347B (zh) 2011-04-13
ES2357588T3 (es) 2011-04-27
CA2576257A1 (en) 2006-02-16
GB2418425A (en) 2006-03-29
CN101014347A (zh) 2007-08-08
IL181055A0 (en) 2007-07-04
IL181055A (en) 2011-03-31
DK1781299T3 (da) 2011-03-28
JP4991540B2 (ja) 2012-08-01
WO2006016152A1 (en) 2006-02-16
US20080194541A1 (en) 2008-08-14
BRPI0514250A (pt) 2008-06-03

Similar Documents

Publication Publication Date Title
NO20071321L (no) Anti-inflammatoriske midler
NO20050828L (no) lndol-3-svovelderivater
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
NO20075042L (no) Farmasoytisk sammensetning innbefattende en omega-karboksyarylsubstituert difenylurea for behandling av cancer
NO20092723L (no) Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20090321L (no) Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
TW200615266A (en) Organic compounds
NO20052883L (no) Nye medikamenter for behandling av kronisk obstruktiv luftveissykdom.
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
TW200619199A (en) 3-carbamoyl-2-pyridone derivatives
MX2010004232A (es) Compuesto de indolina de pirimidilo.
NO20071314L (no) Peptidiske vasopressinreseptoragonister
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
NO20062983L (no) Sulfonamid-derivater for behandling av sykdommer
NO20040881L (no) Orale antidiabetes midler.
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
MX2022008487A (es) Degradadores de smarca2-vhl.
CY1111574T1 (el) Παραγωγα βουτανοϊκου οξεος, διαδικασιες για την παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και θεραπευτικες εφαρμογες αυτων
NO20032261L (no) Medisinske preparater
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20044531L (no) Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom
DE602005025228D1 (de) Entzündungshemmende wirkstoffe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application